Effect of trifluoroacetic acid on the antigenicity of capsular polysaccharides obtained from various Streptococcus pneumoniae serotypes

• Published in: Carbohydrate polymers 2023-11, Vol.320, p.121204-121204, Article 121204
• Main Authors: Gaikwad, Walmik Karbhari, Dhere, Rajeev M., Jana, Swapan K., Mallya, Asha D., Soni, Dipen J., Gholap, Makrand, Ravenscroft, Neil, Kodam, Kisan M.
• Format: Article
• Language: English
• Subjects: Antigenicity; CRM197; Immunogenicity; Pneumococcal conjugate vaccine; Streptococcus pneumoniae; Trifluoroacetic acid
• ISSN: 0144-8617; 1879-1344
• DOI: 10.1016/j.carbpol.2023.121204

Determining the safety, antigenicity, and immunogenicity by in vitro and in vivo studies is a prerequisite for the development of new vaccines. And this study investigated it for a vaccine made from Streptococcus pneumoniae serotypes 2, 5, 12F, 18C, and 22F. The crude CPS was purified and partially depolymerized by conventional and trifluoroacetic acid methods. 1H NMR analysis confirmed the identity of the depolymerized CPS which gave similar profiles to reference polysaccharides, except for serotype 18C which was de-O-acetylated during TFA treatment. The antigenicity of the depolymerized CPS prepared by either method was comparable to that of the native CPS for serotypes 2, 5, 18C, and 22F based on multiplex bead based competitive inhibition assay. This study demonstrated a relationship between antigenicity and immunogenicity, which offers more suitable candidates for conjugation. It was found that after partial depolymerization process, the CPS with optimal molecular size resulted in higher antigenicity. The immunogenicity of S. pneumoniae serotype 2 conjugates in mice was evaluated by opsonophagocytic assay and a multiplex bead-based assay, wherein on day 42 after immunization, the total and functional IgG titer was found to be increased by 32-fold. [Display omitted]